Metraipolis › archive › dc_eca199d8668b
Impact of Universal Nirsevimab Immunoprophylaxis on RSV-Related Hospitalizations in Infants: A Two-Season Multicenter Study in Northern Italy — Europe PMC PMID:42515025
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42515025
- DOI
- 10.3390/pathogens15070698
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T08:29:26.591Z
- SHA-256 of the archived text
7bc93b16a5bd5860c1123ce17dc357a1b9be8be496baed778bd47fa269d6e361- Stable URL of this page
https://metraipolis.com/documento/dc_eca199d8668b
How to cite
Impact of Universal Nirsevimab Immunoprophylaxis on RSV-Related Hospitalizations in Infants: A Two-Season Multicenter Study in Northern Italy — Europe PMC PMID:42515025 — Europe PMC (en), https://europepmc.org/article/MED/42515025 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eca199d8668b (Metraipolis archive dc_eca199d8668b, sha256 7bc93b16a5bd5860c1123ce17dc357a1b9be8be496baed778bd47fa269d6e361)
BibTeX
@misc{dceca199d8668b,
title = {Impact of Universal Nirsevimab Immunoprophylaxis on RSV-Related Hospitalizations in Infants: A Two-Season Multicenter Study in Northern Italy — Europe PMC PMID:42515025},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42515025},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eca199d8668b; sha256 7bc93b16a5bd5860c1123ce17dc357a1b9be8be496baed778bd47fa269d6e361},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42515025. Agents can read the archived copy with the MCP tool read_document.